Search Results
Jun 25, 2025, 20:38 ET BioCity's ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria
assets in clinical development, including first-in-class CDH3- and GPC3-targeting antibody drug conjugates (ADCs), WEE1 and ATR inhibitors targeting the DNA damage response (DDR) pathway, and a monoclonal antibody targeting TIM-3. For more information, please visit:
More news about: BioCity Biopharma
Jun 25, 2025, 17:31 ET DHODH Inhibitors Market Forecast to Reach New Heights by 2034 Owing to the Expanding Applications in Oncology and Autoimmune Diseases | DelveInsight
mitochondrial pathway responsible for de novo pyrimidine synthesis, crucial building blocks for DNA and RNA. By disrupting this process, these drugs reduce the supply of pyrimidines, thereby hindering DNA production and triggering cell cycle arrest, especially in fast-dividing cells. These agents
More news about: DelveInsight Business Research, LLP
Jun 25, 2025, 12:01 ET Ancestry® appoints Jody Gerson, Chairman and CEO of Universal Music Publishing Group, to its Board of Directors
family stories. With our unparalleled collection of more than 65 billion records, over 3 million subscribers and over 27 million people in our growing DNA network, customers can discover their family story and gain a new level of understanding about their lives. Over the past 40 years, we've built trusted
More news about: Ancestry
Jun 25, 2025, 10:15 ET Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer
inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in areas including neuroscience, brain-related diseases, inherited disorders, diabetes, obesity, and gait and balance, RFU
More news about: Rosalind Franklin University of Medicine and Science
Jun 25, 2025, 09:07 ET Swanson Health Earns 'A' Rating Under NSF/ANSI 455-2 GMP Certification for Dietary Supplements
training and education, consulting, clinical research, regulatory guidance, corporate compliance and, separately, auditing, GMP and GLP analytical testing, DNA testing, certification and R&D for the pharma biotech, medical device and dietary supplement industries throughout the product lifecycle. CONTACT: Brilliant
More news about: Swanson Health
Jun 25, 2025, 05:00 ET Bluecrux appoints four new partners to bolster global leadership and growth
Business Unit for Supply Chain Operations. Throughout her tenure, she has played a central role in shaping the company's culture and organizational DNA. She is widely respected for consistently setting high standards in project delivery and internal excellence, qualities that have become a cornerstone
More news about: Bluecrux
Jun 25, 2025, 05:00 ET Bluecrux appoints four new partners to bolster global leadership and growth
Business Unit for Supply Chain Operations. Throughout her tenure, she has played a central role in shaping the company's culture and organizational DNA. She is widely respected for consistently setting high standards in project delivery and internal excellence, qualities that have become a cornerstone
More news about: Bluecrux
Jun 25, 2025, 02:00 ET Novo Nordisk Foundation and University of Copenhagen announce USD 109 million grant to new Danish research centre to make designed proteins with vast potential
internationally. Proteins are the workhorses of biology. They perform virtually every important function in living organisms. They store, copy and protect our DNA, digest food to give us energy, and harness this energy to make our cells and muscles work. But imagine if proteins could be specifically designed
More news about: Novo Nordisk Foundation; University of Copenhagen
Jun 25, 2025, 00:48 ET Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Jun 24, 2025, 20:24 ET Zymo Research Unveils MultiOmiX Workstation with Show-Stopping Launch at ASM Microbe 2025
workflow. Simultaneous DNA and RNA purification from the same sampleAutomated purification and library preparationProcessing of up to 96 samples per runPre-scripted workflows – no coding requiredSupport for both DNA-Seq and RNA-Seq for metagenomic and
More news about: Zymo Research Corp.
Jun 24, 2025, 15:54 ET A Glimpse Into the Future of Mass Spectrometry: Game-Changing Technologies and Transformative Trends Unveiled at ASMS 2025
of innovation—it was the philosophical shift: accessibility, efficiency, and modularity are no longer aspirational; they are becoming embedded in the DNA of next-generation systems. From high-end proteomics to on-site environmental monitoring, this year's launches suggest that the impact of mass spectrometry
More news about: Instrument Business Outlook
Jun 24, 2025, 09:00 ET Springline Advisory Earns Breakthrough Culture Award for Exceptional Workplace Culture
how it assesses and determines future founding firms that join Springline."'Scale with Soul™' isn't just a tagline, it's the very DNA of our culture and how we approach growth," said Tim Brackney, CEO at Springline Advisory. "This recognition validates
More news about: Springline Advisory
Jun 24, 2025, 09:00 ET BioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 Congress
transition period. Malignancy: The integration of liver-targeting AAV vector DNA into the genome may carry the theoretical risk of hepatocellular carcinoma development. ROCTAVIAN can also insert into the DNA of other human body cells. Monitor patients with risk factors for hepatocellular carcinoma
More news about: BioMarin Pharmaceutical Inc.
Jun 24, 2025, 08:15 ET MDA SPACE AWARDED $60 MILLION FOR NEXT PHASE OF RIVER-CLASS DESTROYER
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Jun 24, 2025, 08:01 ET PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing
addition to Veris), Lucid Diagnostics, is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device—the first and only commercial tools for widespread early detection of esophageal precancer
More news about: PAVmed Inc.
Jun 24, 2025, 06:55 ET L'ORÉAL PARIS DOCUMENTARY WINS GRAND PRIX IN FILM AT CANNES LIONS 2025
quoi, an empowering vision of self-confidence to imbue every woman with a sense of self-worth. The French heritage of the brand is essential to its DNA, a vision expressed on the world stage with L'Oréal Paris participation in the most glamorous events, projecting Parisian excellence and diversity across
More news about: McCann
Jun 24, 2025, 06:28 ET L'ORÉAL PARIS DOCUMENTARY WINS GRAND PRIX IN FILM AT CANNES LIONS 2025
quoi, an empowering vision of self-confidence to imbue every woman with a sense of self-worth. The French heritage of the brand is essential to its DNA, a vision expressed on the world stage with L'Oréal Paris participation in the most glamorous events, projecting Parisian excellence and
More news about: McCann
Jun 24, 2025, 05:00 ET Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population
such as ALS, Alzheimer's, and Parkinson's disease. The company's current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. The company is managed by a team of individuals and advisors who are highly experienced
More news about: Klotho Neurosciences, Inc.
Jun 24, 2025, 05:00 ET Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population
such as ALS, Alzheimer's, and Parkinson's disease. The company's current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. The company is managed by a team of individuals and advisors who are highly experienced
More news about: Klotho Neurosciences, Inc.
Jun 23, 2025, 16:30 ET SAVE LIKE A PRO, EAT LIKE A LEGEND: TACO BELL® TEAMS WITH TONY HAWK FOR HIS TAKE ON BUILD YOUR OWN LUXE CRAVINGS BOX + UNIQUE IN-GAME ITEMS
"At Taco Bell, delivering bold flavor at unbeatable value for our fans isn't a trend—it's part of our DNA" said Taco Bell's Chief Marketing Officer, Taylor Montgomery. "We're seeing 1 in 5 Luxe Cravings Boxes being scooped up
More news about: Taco Bell Corp.
Jun 23, 2025, 11:30 ET Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medicine & Molecular Imaging Annual Meeting
Pluvicto treatment. ATNM-400 leverages the alpha-particle emitter Ac-225, which is more potent than Lu-177, can cause lethal irreversible double-stranded DNA breaks, and has a shorter path length that could result in fewer off-target effects. About Actinium Pharmaceuticals, Inc. Actinium
More news about: Actinium Pharmaceuticals, Inc.
Jun 23, 2025, 10:39 ET Real People, Real Influence: Xiaohongshu's Native Marketing Model "Seeding" Debuts at Cannes Lions
the company's annual goal as prioritizing the health of the community ecosystem instead of user growth, fostering "authenticity" within the platform's DNA. This ecosystem, rooted in sharing authentic life experiences, fuels Xiaohongshu's vibrant community and lays the building blocks for "seeding".
More news about: Xiaohongshu
Jun 23, 2025, 09:00 ET New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation
The study evaluated a biosensor to track loss of lean muscle mass (LLMM) and protein ingestion in patients taking incretin based therapies. Using a DNA-based bioreceptor (called an aptamer), the sensor was designed to detect phenylalanine, and a key biomarker released during muscle breakdown or after
More news about: American Diabetes Association
Jun 23, 2025, 07:38 ET TCL Celebrates International Olympic Day with Donors' Wall Unveiling at Olympic Museum
thank you so much for this incredible donation. You told me that moving fast is something in the TCL spirit, and that is definitely something in the DNA of the Olympic Movement. We look forward to moving even faster with you in the future – as President Bach said, 'the sky is the limit'". Global
More news about: TCL
Jun 23, 2025, 07:13 ET Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.